FDx Advisors Inc. trimmed its position in Quest Diagnostics Incorporated (NYSE:DGX – Get Rating) by 10.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,751 shares of the medical research company’s stock after selling 1,267 shares during the period. […]